JPMorgan lowered the firm’s price target on Walgreens Boots Alliance to $15 from $20 and keeps an Overweight rating on the shares. The firm cut estimates after revisiting its fiscal 2025 expectations.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on WBA:
- Bilt Rewards enters strategic collaboration with Walgreens Boots Alliance
- Class Action Lawsuit Against Walgreens Boots Alliance (NASDAQ:WBA)
- Walgreens, BARDA form decentralized clinical trials partnership
- Walgreens (WBA) May Exit the S&P 500, But Hope Remains
- Ex-Dividend Date Nearing for These 10 Stocks – Week of August 19, 2024